We established the Young Blood Institute to study new medical uses for well established blood plasma replacement therapies and, after many years of pre-clinical study and observation, have recently focused our efforts on the treatment and prevention of Alzheimer's disease, following in the footsteps of the Grifols AMBAR study and the Ace Alzheimer Center in Barcelona. We call it the The AmβARI Study for Amyloid βeta Assessment & Removal Intervention.
